Tempe-based Clinical Research Advantage (CRA), the country’s largest wholly owned network of clinical trial sites, announced that the company’s President & Chief Operating Officer,  David M. Bruggeman, has been selected by PharmaVOICE Magazine as one of the 100 most inspiring people in the life sciences industry. Bruggeman, a 30-year healthcare industry veteran, was honored for his vision and innovation in the clinical trials industry.

Since acquiring CRA in 2007, Bruggeman has been the pioneering force behind the development of an integrated platform for clinical research. This platform has allowed CRA to standardize its research procedures and make the trial process safer and more efficient. It has also enabled CRA to expand rapidly – growing from just six sites in Phoenix to more than 60 sites across the country in the past six years.

“David is an inspiring leader who is dedicated to furthering our industry,” said Mark S. Hanley, CRA’s Chief Executive Officer.  “David’s work has improved the quality and efficiency of clinical trials and improved the patient experience. On behalf of the CRA team, I’d like to congratulate David on this well-deserved honor.”

The PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. Nominated by thousands of PharmaVOICE readers, the recipients are selected based on comprehensive essays describing how they have inspired or motivated their colleagues, peers and others; and how they have affected positive change in their organizations or communities. The individuals of the PharmaVOICE 100 represent a broad cross section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, technology and many others.